119 related articles for article (PubMed ID: 14613643)
1. [Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma].
Han JL; Xie WL; Huang J; Yao YS
Ai Zheng; 2003 Nov; 22(11):1158-61. PubMed ID: 14613643
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
3. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
5. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma.
Rosenthal EL; Shreenivas S; Peters GE; Grizzle WE; Desmond R; Gladson CL
Laryngoscope; 2003 Aug; 113(8):1406-10. PubMed ID: 12897567
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
7. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
8. Expression of emmprin by oral squamous cell carcinoma.
Bordador LC; Li X; Toole B; Chen B; Regezi J; Zardi L; Hu Y; Ramos DM
Int J Cancer; 2000 Feb; 85(3):347-52. PubMed ID: 10652425
[TBL] [Abstract][Full Text] [Related]
9. Comparison of p38MAPK (mitogene activated protein kinase), p65 NFkappaB (nuclear factor kappa b) and EMMPRIN (extracellular matrix metalloproteinase inducer) expressions with tumor grade and stage of superficial and invasive bladder tumors.
Ozbek E; Otunctemur A; Calik G; Aliskan T; Cakir S; Dursun M; Somay A
Arch Ital Urol Androl; 2011 Dec; 83(4):181-7. PubMed ID: 22670315
[TBL] [Abstract][Full Text] [Related]
10. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions.
Caudroy S; Polette M; Tournier JM; Burlet H; Toole B; Zucker S; Birembaut P
J Histochem Cytochem; 1999 Dec; 47(12):1575-80. PubMed ID: 10567441
[TBL] [Abstract][Full Text] [Related]
11. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN (CD 147) is expressed in Hodgkin's lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases.
Thorns C; Feller AC; Merz H
Anticancer Res; 2002; 22(4):1983-6. PubMed ID: 12174874
[TBL] [Abstract][Full Text] [Related]
13. [Expression of extracellular matrix metalloproteinase inducer in laryngeal squamous cell carcinoma].
Ma J; Qiao Z; Wu S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun; 19(12):545-7. PubMed ID: 16176007
[TBL] [Abstract][Full Text] [Related]
14. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
15. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Gabison EE; Mourah S; Steinfels E; Yan L; Hoang-Xuan T; Watsky MA; De Wever B; Calvo F; Mauviel A; Menashi S
Am J Pathol; 2005 Jan; 166(1):209-19. PubMed ID: 15632013
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN expression in tongue squamous cell carcinoma.
Huang Z; Huang H; Li H; Chen W; Pan C
J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
[TBL] [Abstract][Full Text] [Related]
18. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
19. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts.
Kanekura T; Chen X; Kanzaki T
Int J Cancer; 2002 Jun; 99(4):520-8. PubMed ID: 11992541
[TBL] [Abstract][Full Text] [Related]
20. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
